Navigation Links
Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Date:8/19/2007

NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Xenomics, Inc. (the "Company") (Pink Sheets: XNOM; FWB: XE7) a developer of next-generation medical DNA diagnostic technologies, announced today that its first diagnostic test developed for stratification of patients with Acute Myeloid Leukemia (AML) has been implemented at CLIA approved BRT Laboratories Inc. in Baltimore, Maryland, and is available for clinicians.

AML is the most common form of acute leukemia with about 13,400 new cases expected in 2007 in the USA and a similar number in Europe. Early detection of AML subtypes is important for development of a treatment strategy. The new test is based on a recent discovery of Drs. Falini and Mecucci at the Institute of Hematology at the University of Perugia in Italy that mutations in a nucleophosmin (NPM1) gene are characteristic of 30-40% of the cases of AML. NPM1 is a protein involved in regulation of ribosome biogenesis, cell division, cell death, and other important processes. Xenomics has obtained an exclusive license for the invention and developed a test that detects all 45 known mutations of NPM1 in a single reaction. The results will help physicians with prognosis, therapy, and monitoring of the disease. Stratification of AML patients is also necessary for anti-AML drug clinical trials.

"We are glad to work with Xenomics on AML diagnostics and to add this test to our repertoire of genetic tests" commented Antonette Allen, Clinical Service Manager of BRT Laboratories. "We believe that the NPM1 diagnostic test will not only help hematologists in the treatment of the disease but also in developing a test for monitoring the disease and patient response to anti-tumor therapy".

About Xenomics, Inc.

Xenomics is a molecular diagnostics company that focuses on the development of DNA-based tests using Transrenal DNA (Tr-DNA). Xenomics' patented technology uses safe and simple urine collection and can be applied to a broad range of application
'/>"/>

SOURCE Xenomics, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...RNewswire-FirstCall/ -- Escalon Medical Corp. (Nas...scal first quarter ended September 30, 2009. ,...evenue decreased approximately $234,000, or 2.7%, ...September 30, 2009 as compared to the same period ...sed net revenue of $8,434,000 compared with $8,669...
(Date:11/20/2009)...Newswire/ -- The United States Court of Appeals f...urt ruling yesterday, approving a settlement in th...aceutical litigation against AstraZeneca Pharmaceu...m/cgi-bin/prnh/20080317/AQM144LOGO ) ,, The rul...o purchased the pharmaceutical giant,s prostate ca...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC ... which develops, licenses, manufactures, distribut...orted its operating results for the first quarter ... excluding royalty income, were $1,683,673 in the ...ported in the previous year first quarter (FY2009)...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 1Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 2Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 3Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 1Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 2All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 1All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 2
...se for trodusquemine determined, PLYMOUTH MEETING... ) today presented data from its dose-escalating,P...1436C-101), the,Company,s product candidate for th... was found to be well-tolerated at likely clinical... healthy overweight and obese adults.,Data were pr...
... 23 Amicus Therapeutics,a biopharmaceutical compa...pharmacological chaperones for the treatment of a ...ositive results from two recently completed,Phase ...Cl) for Pompe,disease. The Phase 1 results show th... with good oral bioavailability and pharmacokineti...
Other Medicine Technology:Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 5Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease 2Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease 3Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease 4
(Date:11/21/2009)... LONDON, November 21, 2009 /PRNewswire-FirstCa...t Test Test Test Test Test Test Test Test Test Tes...t Test Test Test Test Test,Test Test Test Test Tes...re test More test More test More test More test Mo...re test More test More test More test More,test Mo...
(Date:11/21/2009)... NH based medical credentialing so...ts industry to form a partnerhsip with Amerinet, I...is partnership will help to transform quality care... (Vocus) November 21, 2009 -- ISG Group, LL...ced a new agreement with Amerinet Inc., a leading ...
(Date:11/21/2009)... Innovative medical apparel compan...ce , San Clemente, Calif.... of breakthrough medical apparel, today announced ...splay at Medica 2009, a leading international trad..., Germany. Medelita inaugurates its men,s collecti...
(Date:11/21/2009)... HAPPYneuron,s most popular and ad...iPhone and iPod Touch. , ...PYneuron,s most popular and addictive game, SplitW...h. Split Words is designed to help banish that ,ti...ords iPhone brain game challenges the brain by e...
(Date:11/21/2009)... Eric J. Hall, president and chief...f America (AFA) issued the following statement reg...tion as part of the new annual wellness for Medica...nd Affordable Care Act" that was introduced l... (PRWEB) November 21, 2009 -- Eric J. Hall, presid...
Breaking Medicine News(10 mins):Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3
... Laboratories,Inc. (NYSE: FRX ), an international...cts, will release its Fiscal 2008 Fourth Quarter,f...s on Tuesday, April 15,2008. Later that day, at 10...nt and Chief Financial Officer, will discuss the,f...
...lbemarle,Corporation (NYSE: ALB ) will hold its q...results on Tuesday, April 22, 2008, at 9:00am ET.,...an be accessed at,Albemarle Corporation,s Web site...-6942 International Dial In # 617-614-4909 P...
... Caring,Advocates will host a free, interactive w...trate a new Internet-based technology: a low cost,...nd implement Living Wills,and Durable Powers of At...tive, much-needed plans., "People,s greatest end-...
...s of estrogen replacement proved more dangerous , ...he continuing search to uncover the benefits and r...gests that the amount of hormone a woman takes may...creased the risk of kidney and heart problems. , ...
...er in the use of robotics for minimally invasive c... Center (BMC) as chief of cardiac surgery. With h...spitals across the country, and the only hospital ...ost common form of heart disease - 16 million Amer...
...e X-Ray Rooms from Film to IDC Digital ...PRNewswire-FirstCall/ - IDC (Imaging Dynamics Comp...idly growing market for,digital radiography, today...ms to replace conventional film X-ray,equipment in...
Other Medicine News:Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings 2Health News:Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET 2Health News:'Interview by Internet' Can Decrease Greatest End-of-Life Fears: It Facilitates Creating Effective Advance Directives, Living Wills 2Health News:HRT Dosing May Determine Risks, Benefits 2Health News:HRT Dosing May Determine Risks, Benefits 3Health News:Robot-assisted minimally-invasive CABG surgery 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 3
Thru-the-Lens Headlight Video Imaging System
ACL 8000
...tudies have shown that the best, least expensive w...he OR to 72-75 degrees, eliminating the need for p...hough, can cause the surgical team some heat disco...surgeons cool regardless of OR temperatures. The l...
...he RX ACCUNET Embolic Protection System is designe...sy filter control when performing carotid stenting...ased filter system that utilizes rapid exchange te...the filter during catheter manipulations. It is av...
Medicine Products: